{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:00:57Z","timestamp":1747108857678,"version":"3.40.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04183-1","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T14:48:12Z","timestamp":1738507692000},"page":"537-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Whole-body effective half-life of radioiodine in children and young adults with papillary thyroid cancer"],"prefix":"10.1007","volume":"88","author":[{"given":"Yizhuo","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taipeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0636-9680","authenticated-orcid":false,"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,2]]},"reference":[{"issue":"6","key":"4183_CR1","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.surg.2020.12.047","volume":"169","author":"X Zhang","year":"2021","unstructured":"X Zhang, L Jiang, L Liu, B Liu, Influence of body mass index at diagnosis on outcome of thyroid cancer in children and adolescents. Surgery 169(6), 1373\u20131378 (2021). https:\/\/doi.org\/10.1016\/j.surg.2020.12.047.","journal-title":"Surgery"},{"key":"4183_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2024.106984","volume":"158","author":"Y Wei","year":"2024","unstructured":"Y. Wei, L. Xiao, L. Liu, L. Shi, Y. Wang, B. Liu, Prognostic implications of lymph node yield in pediatric patients with N1b papillary thyroid cancer. Oral. Oncol. 158, 106984 (2024). https:\/\/doi.org\/10.1016\/j.oraloncology.2024.106984","journal-title":"Oral. Oncol."},{"issue":"6","key":"4183_CR3","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/ohn.373","volume":"169","author":"Y Xu","year":"2023","unstructured":"Y Xu, L Shi, J Wu, H Li, Y Wang, B Liu, Prognostic value of tumor multifocality in pediatric papillary thyroid carcinoma: a Real-Life Multicentric Study. Otolaryngol. Head. Neck Surg. 169(6), 1606\u20131614 (2023). https:\/\/doi.org\/10.1002\/ohn.373.","journal-title":"Otolaryngol. Head. Neck Surg."},{"issue":"7","key":"4183_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1089\/thy.2014.0460","volume":"25","author":"GL Francis","year":"2015","unstructured":"G.L Francis, S.G Waguespack, A.J Bauer, P Angelos, S Benvenga, J.M Cerutti, C.A Dinauer, J Hamilton, I.D Hay, M Luster, M.T Parisi, M Rachmiel, G.B Thompson, S Yamashita, Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25(7), 716\u2013759 (2015). https:\/\/doi.org\/10.1089\/thy.2014.0460.","journal-title":"Thyroid"},{"issue":"3","key":"4183_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ecl.2007.04.002","volume":"36","author":"C Dinauer","year":"2007","unstructured":"C Dinauer, G.L Francis, Thyroid cancer in children. Endocrinol. Metab. Clin. North. Am. 36(3), 779\u2013806 (2007). https:\/\/doi.org\/10.1016\/j.ecl.2007.04.002.","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"4","key":"4183_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1677\/erc.1.00880","volume":"12","author":"B Jarza\u0328b","year":"2005","unstructured":"B Jarza\u0328b, D Handkiewicz-Junak, J W\u0142och, Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr. Relat. Cancer 12(4), 773\u2013803 (2005). https:\/\/doi.org\/10.1677\/erc.1.00880.","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"4183_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/105072502760258668","volume":"12","author":"W Hung","year":"2002","unstructured":"W Hung, N.J Sarlis, Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid 12(8), 683\u2013702 (2002). https:\/\/doi.org\/10.1089\/105072502760258668.","journal-title":"Thyroid"},{"issue":"5","key":"4183_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/med.0000000000000754","volume":"29","author":"M Goldfarb","year":"2022","unstructured":"M Goldfarb, C Dinauer, Differences in the management of thyroid nodules in children and adolescents as compared to adults. Curr. Opin. Endocrinol. Diabetes Obes. 29(5), 466\u2013473 (2022). https:\/\/doi.org\/10.1097\/med.0000000000000754.","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"11","key":"4183_CR9","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1007\/s00259-023-06295-0","volume":"50","author":"J Taprogge","year":"2023","unstructured":"J Taprogge, A Vergara-Gil, F Leek, C Abreu, L V\u00e1vrov\u00e1, L Carnegie-Peake, S Schumann, U Eberlein, M Lassmann, T Schurrat, M Luster, F.A Verburg, D Vallot, L Vija, F Courbon, K Newbold, M Bardi\u00e8s, G Flux, Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national horizon 2020 medirad project. Eur. J. Nucl. Med. Mol. Imaging 50(11), 3225\u20133234 (2023). https:\/\/doi.org\/10.1007\/s00259-023-06295-0.","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"4183_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00259-010-1398-0","volume":"37","author":"M Salvatori","year":"2010","unstructured":"M Salvatori, M Luster, Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma. Eur. J. Nucl. Med. Mol. Imaging 37(4), 821\u2013828 (2010). https:\/\/doi.org\/10.1007\/s00259-010-1398-0.","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"9","key":"4183_CR11","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s00247-021-05039-2","volume":"51","author":"L Jiang","year":"2021","unstructured":"L Jiang, Y Xiang, R Huang, R Tian, B Liu, Clinical applications of single-photon emission computed tomography\/computed tomography in post-ablation 131iodine scintigraphy in children and young adults with differentiated thyroid carcinoma. Pediatr. Radiol. 51(9), 1724\u20131731 (2021). https:\/\/doi.org\/10.1007\/s00247-021-05039-2.","journal-title":"Pediatr. Radiol."},{"issue":"1","key":"4183_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1148\/radiol.14132234","volume":"273","author":"B Liu","year":"2014","unstructured":"B Liu, W Peng, R Huang, R Tian, Y Zeng, A Kuang, Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements. Radiology 273(1), 211\u2013219 (2014). https:\/\/doi.org\/10.1148\/radiol.14132234.","journal-title":"Radiology"},{"issue":"9","key":"4183_CR13","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.2967\/jnumed.109.064469","volume":"50","author":"SE Buckley","year":"2009","unstructured":"S.E Buckley, S.J Chittenden, F.H Saran, S.T Meller, G.D Flux, Whole-body dosimetry for individualized treatment planning of 131I-MIBG radionuclide therapy for neuroblastoma. J. Nucl. Med. 50(9), 1518\u20131524 (2009). https:\/\/doi.org\/10.2967\/jnumed.109.064469.","journal-title":"J. Nucl. Med."},{"key":"4183_CR14","doi-asserted-by":"crossref","unstructured":"M. Cristy, K. Eckerman, Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. ORNL\/TM-8381 V1-V7. (Oak Ridge National Laboratory. Oak Ridge, TN, 1987).","DOI":"10.2172\/6233735"},{"issue":"17","key":"4183_CR15","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"R.D Mosteller, Simplified calculation of body-surface area. N. Engl. J. Med. 317(17), 1098 (1987). https:\/\/doi.org\/10.1056\/NEJM198710223171717.","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"4183_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/ndt\/gfw425","volume":"32","author":"H Pottel","year":"2017","unstructured":"H Pottel, P Delanaye, E Schaeffner, L Dubourg, B.O Eriksen, T Melsom, E.J Lamb, A.D Rule, S.T Turner, R.J Glassock, VDe Souza, L Selistre, K Goffin, S Pauwels, C Mariat, M Flamant, N Ebert, Estimating glomerular filtration rate for the full age spectrum from serum creatinine and Cystatin C. Nephrol. Dial. Transplant. 32(3), 497\u2013507 (2017). https:\/\/doi.org\/10.1093\/ndt\/gfw425.","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"4183_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/thy.2017.0214","volume":"28","author":"MJ Jeon","year":"2018","unstructured":"M.J Jeon, Y.N Kim, T.-Y Sung, S.J Hong, Y.Y Cho, T.Y Kim, Y.K Shong, W.B Kim, S.W Kim, J.H Chung, T.H Kim, W.G Kim, Practical initial risk stratification based on lymph node metastases in pediatric and adolescent differentiated thyroid cancer. Thyroid 28(2), 193\u2013200 (2018). https:\/\/doi.org\/10.1089\/thy.2017.0214.","journal-title":"Thyroid"},{"issue":"7","key":"4183_CR18","first-page":"1065","volume":"44","author":"C Menzel","year":"2003","unstructured":"C Menzel, W.T Kranert, N D\u00f6bert, M Diehl, T Fietz, N Hamscho, U Berner, F Gr\u00fcnwald, Rhtsh stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of 131I. J. Nucl. Med. 44(7), 1065\u20131068 (2003).","journal-title":"J. Nucl. Med."},{"issue":"9","key":"4183_CR19","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2967\/jnumed.108.052464","volume":"49","author":"H Remy","year":"2008","unstructured":"H Remy, I Borget, S Leboulleux, N Guilabert, F Lavielle, J Garsi, C Bournaud, S Gupta, M Schlumberger, M Ricard, 131I effective half-life and dosimetry in thyroid cancer patients. J. Nucl. Med. 49(9), 1445\u20131450 (2008). https:\/\/doi.org\/10.2967\/jnumed.108.052464.","journal-title":"J. Nucl. Med."},{"issue":"7","key":"4183_CR20","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1210\/jc.2009-2528","volume":"95","author":"D Ta\u00efeb","year":"2010","unstructured":"D Ta\u00efeb, F Sebag, B Farman-Ara, T Portal, K Baumstarck-Barrau, C Fortanier, M Bourrelly, J Mancini, CDe Micco, P Auquier, B Conte-Devolx, J.F Henry, O Mundler, Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal. J. Clin. Endocrinol. Metab. 95(7), 3283\u20133290 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2528.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4183_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/1754-9485.12238","volume":"59","author":"S Grenfell","year":"2015","unstructured":"S Grenfell, D Roos, J Rijken, B Higgs, I Kirkwood, Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: a Retrospective Study. J. Med. Imaging Radiat. Oncol. 59(2), 248\u2013254 (2015). https:\/\/doi.org\/10.1111\/1754-9485.12238.","journal-title":"J. Med. Imaging Radiat. Oncol."},{"issue":"1","key":"4183_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/1450-1147.138576","volume":"13","author":"R Ravichandran","year":"2014","unstructured":"R Ravichandran, A Al Saadi, N Al Balushi, Radioactive body burden measurements in 131Iodine therapy for differentiated thyroid cancer: effect of recombinant thyroid stimulating hormone in whole body 131Iodine clearance. World J. Nucl. Med. 13(1), 56\u201361 (2014). https:\/\/doi.org\/10.4103\/1450-1147.138576.","journal-title":"World J. Nucl. Med."},{"issue":"5","key":"4183_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2967\/jnumed.118.217638","volume":"60","author":"R Bacher","year":"2019","unstructured":"R Bacher, M Hohberg, M Dietlein, M Wild, C Kobe, A Drzezga, M Schmidt, Thyroid uptake and effective half-life of radioiodine in thyroid cancer patients at radioiodine therapy and follow-up whole-body scintigraphy either in hypothyroidism or under rhtsh. J. Nucl. Med. 60(5), 631\u2013637 (2019). https:\/\/doi.org\/10.2967\/jnumed.118.217638.","journal-title":"J. Nucl. Med."},{"issue":"2","key":"4183_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000239090","volume":"38","author":"DJ Edwards","year":"1992","unstructured":"D.J Edwards, K Stoeckel, The pharmacokinetics of new oral cephalosporins in children. Chemotherapy 38(2), 2\u20139 (1992). https:\/\/doi.org\/10.1159\/000239090.","journal-title":"Chemotherapy"},{"issue":"9","key":"4183_CR25","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1111\/bcp.15368","volume":"88","author":"Y Qin","year":"2022","unstructured":"Y Qin, L.L Zhang, Y.R Ye, Y.T Chen, Z Jiao, Parametric population pharmacokinetics of linezolid: a systematic review. Br. J. Clin. Pharmacol. 88(9), 4043\u20134066 (2022). https:\/\/doi.org\/10.1111\/bcp.15368.","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"4183_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/asn.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"G.J Schwartz, A Munoz, M.F Schneider, R.H Mak, F Kaskel, B.A Warady, S.L Furth, New equations to estimate GFR in children with Ckd. J. Am. Soc. Nephrol. 20(3), 629\u2013637 (2009). https:\/\/doi.org\/10.1681\/asn.2008030287.","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"4183_CR27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3390\/diagnostics11101740","volume":"11","author":"M Klain","year":"2021","unstructured":"M Klain, C Nappi, MDe Risi, L Piscopo, F Volpe, M Manganelli, E Caiazzo, D Bianco, M Schlumberger, A Cuocolo, Whole-body radioiodine effective half-life in patients with differentiated thyroid cancer. Diagnostics 11(10), 1740 (2021). https:\/\/doi.org\/10.3390\/diagnostics11101740.","journal-title":"Diagnostics"},{"issue":"1","key":"4183_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2967\/jnmt.120.246512","volume":"49","author":"P Paolo de Barros","year":"2021","unstructured":"P Paolo de Barros, T.S Cagol Camozzato, T Jahn, F.A Penna Soares, L Machado da Silva, Jde Aguiar Soares, M.A Neiva Koslosky, Analysis of radiometry on patients undergoing radioactive iodine therapy. J. Nucl. Med. Technol. 49(1), 75\u201381 (2021). https:\/\/doi.org\/10.2967\/jnmt.120.246512.","journal-title":"J. Nucl. Med. Technol."},{"issue":"10","key":"4183_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3390\/diagnostics14101010","volume":"14","author":"YK Tsai","year":"2024","unstructured":"Y.K Tsai, L.F Lin, C.Y Cheng, C.Y.O Wong, W.H Wang, D.H.Y Shen, S.L Su, E.S Chen, T.Y Chen, I.F Chen, Simplified assessment of radioiodine biokinetics for thyroid cancer patients: a practical approach using continuous external radiation monitoring. Diagnostics 14(10), 1010 (2024). https:\/\/doi.org\/10.3390\/diagnostics14101010.","journal-title":"Diagnostics"},{"issue":"3","key":"4183_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s12020-018-1800-4","volume":"63","author":"M Freesmeyer","year":"2019","unstructured":"M Freesmeyer, F G\u00fchne, C K\u00fchnel, T Opfermann, T Winkens, A Werner, Determination of effective half-life of 131I in patients with differentiated thyroid carcinoma: comparison of Cystatin C and creatinine-based estimation of renal function. Endocrine 63(3), 554\u2013562 (2019). https:\/\/doi.org\/10.1007\/s12020-018-1800-4.","journal-title":"Endocrine"},{"issue":"2","key":"4183_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00411-018-0736-7","volume":"57","author":"P Jin","year":"2018","unstructured":"P Jin, H Feng, W Ouyang, J Wu, P Chen, J Wang, Y Sun, J Xian, L Huang, Radiation dose rates of differentiated thyroid cancer patients after 131I therapy. Radiat. Environ. Biophys. 57(2), 169\u2013177 (2018). https:\/\/doi.org\/10.1007\/s00411-018-0736-7.","journal-title":"Radiat. Environ. Biophys."},{"key":"4183_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejmp.2021.06.012","volume":"88","author":"P M\u00ednguez","year":"2021","unstructured":"P. M\u00ednguez, J. Genoll\u00e1, M. Dom\u00ednguez, A. Exp\u00f3sito, B. Santos, E. Rode\u00f1o, Dependency of the remnant 131I-NaI biokinetics on the administered activity in patients with differentiated thyroid cancer. Phys. Med. 88, 45\u201352 (2021). https:\/\/doi.org\/10.1016\/j.ejmp.2021.06.012","journal-title":"Phys. Med."},{"issue":"7","key":"4183_CR33","doi-asserted-by":"publisher","first-page":"e00248","DOI":"10.1128\/AAC.00248-19","volume":"63","author":"XM Yang","year":"2019","unstructured":"X.M Yang, S Leroux, T Storme, D.L Zhang, T.Ade Beaumais, H.Y Shi, Y.L Yang, X.L Wang, W Zhao, E Jacqz-Aigrain, Body surface area-based dosing regimen of caspofungin in children: a population pharmacokinetics Confirmatory Study. Antimicrob. Agents Chemother. 63(7), e00248\u201300219 (2019). https:\/\/doi.org\/10.1128\/AAC.00248-19.","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"4183_CR34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40262-023-01210-0","volume":"62","author":"NS Ly","year":"2023","unstructured":"N.S Ly, J Li, R Faggioni, L.K Roskos, M.S Brose, Population pharmacokinetics and exposure\u2013response analysis for the phase 3 Cosmic-311 trial of cabozantinib for radioiodine-refractory differentiated thyroid cancer. Clin. Pharmacokinet. 62(4), 587\u2013598 (2023). https:\/\/doi.org\/10.1007\/s40262-023-01210-0.","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"4183_CR35","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/cpt.3250","volume":"116","author":"ZL Taylor","year":"2024","unstructured":"Z.L Taylor, F.G Green, N Hossain, G.J Burckart, M Pacanowski, R.N Schuck, Assessment of dosing strategies for pediatric drug products. Clin. Pharmacol. Ther. 116(3), 716\u2013723 (2024). https:\/\/doi.org\/10.1002\/cpt.3250.","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"4183_CR36","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1007\/s00259-020-04741-x","volume":"47","author":"JE Gains","year":"2020","unstructured":"J.E Gains, V Moroz, M.D Aldridge, S Wan, K Wheatley, J Laidler, C Peet, J.B Bomanji, M.N Gaze, A phase iia trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma. Eur. J. Nucl. Med. Mol. Imaging 47(10), 2348\u20132357 (2020). https:\/\/doi.org\/10.1007\/s00259-020-04741-x.","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04183-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:47:33Z","timestamp":1747036053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,2]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["4183"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04183-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2025,2,2]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The original survey protocol was approved by the Institutional Review Board of West China Hospital, Sichuan University. The requirement of written informed consent was waived by the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors read the manuscript and agreed to its publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}